| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 06/15/2011 | EP2332561A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/15/2011 | EP2332541A1 Use of thioxanthine derivatives as MPO inhibitors |
| 06/15/2011 | EP2331137A1 New combination of active ingredients containing an alpha-1antagonist and a pde 4 inhibitor |
| 06/15/2011 | EP2331135A1 Methods of treating and preventing glucose toxicity |
| 06/15/2011 | EP1619185B1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof |
| 06/15/2011 | EP1349558B1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 06/15/2011 | EP1175400B1 Renin inhibitors |
| 06/15/2011 | CN1997621B Crystalline forms of (-)-(1r,2r)-3-(3-dimethyl amino-1-ethyl-2-methyl propyl)-phenol hydrochloride |
| 06/15/2011 | CN1930145B Cycloalkanopyridine derivative |
| 06/15/2011 | CN1832948B 1- alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 06/15/2011 | CN1813862B Chinese medicine composition for treating chyluria |
| 06/15/2011 | CN1700923B Multi-substituted selective androgen receptor modulators and methods of use thereof |
| 06/15/2011 | CN102099358A Compound with serotoninergic activity, process for preparing same and pharmaceutical composition comprising same |
| 06/15/2011 | CN102099334A Novel compounds active as muscarinic receptor antagonists |
| 06/15/2011 | CN102099033A Pharmaceutical composition for treatment of fibromyalgia |
| 06/15/2011 | CN102099024A Use of nitrated lipids for treatment of side effects of toxic medical therapies |
| 06/15/2011 | CN102093944A Chinese medicinal wine |
| 06/15/2011 | CN102093460A Triterpenoid saponin compound as well as synthesis method and application of triterpenoid saponin |
| 06/15/2011 | CN102091330A Pharmaceutical compositions comprising valsartan and NEP inhibitors |
| 06/15/2011 | CN102091294A Traditional Chinese medicine composition for treating uremia |
| 06/15/2011 | CN102091293A Traditional Chinese medicine composition for treating renal cyst |
| 06/15/2011 | CN102091276A Traditional Chinese medicine composition for treating prostatic hypertrophy and preparation method thereof |
| 06/15/2011 | CN102091263A Application of Chinese medicine composition in preparation of medicament for treating overhigh level of urine cell factor or receptor thereof and Escherichia coli infection |
| 06/15/2011 | CN102091256A Specific medicinal liquor and preparation thereof for treating prostatitis and inflammations of genitourinary system |
| 06/15/2011 | CN102091249A Traditional Chinese medicine for treating recurrent bladder cancer |
| 06/15/2011 | CN102091248A Vegetable medicament formula for preventing and treating all kinds of calculosis and preparation method thereof |
| 06/15/2011 | CN102091225A Traditional Chinese medicine for treating chronic prostatitis |
| 06/15/2011 | CN102091193A Oral medicine for treating urolithiasis |
| 06/15/2011 | CN102091188A Traditional Chinese medicine for treating diabetic kidney diseases |
| 06/15/2011 | CN102091157A Traditional Chinese medicine for treating hyperplasia of prostate |
| 06/15/2011 | CN102091149A Method for preparing traditional Chinese medicine product |
| 06/15/2011 | CN102091131A New application of lotus plumule or extract thereof |
| 06/15/2011 | CN102091093A Active ionophore preparation--Weikangsu powder prepared from natural ores and preparation and application methods thereof |
| 06/15/2011 | CN102091068A Indole, benzofuran and benzothiophene derivatives as selective androgen receptor modulators (SARMS) |
| 06/15/2011 | CN102091040A Preparation process of fine rutin particles |
| 06/15/2011 | CN102090819A Far infrared anti-electromagnetic wave body-perfuming sleeping bag used for teenagers, comprising nano selenium and traditional Chinese medicinal materials and capable of generating negative ions |
| 06/15/2011 | CN102090636A PUFA supplements |
| 06/15/2011 | CN101810792B Chinese medicinal composition for treating kidney failure diseases and preparation method thereof |
| 06/15/2011 | CN101690782B Chinese medicinal preparation |
| 06/15/2011 | CN101637548B Medicine for treating kidney stone and preparation method thereof |
| 06/15/2011 | CN101537077B Chinese medicinal mixed tincture |
| 06/15/2011 | CN101522194B Prophylactic/therapeutic agent for renal dysfunction |
| 06/15/2011 | CN101518607B Traditional Chinese medicine for treating carcinoma of kidney |
| 06/15/2011 | CN101472574B Agent for increasing testosterone level |
| 06/15/2011 | CN101259188B Chinese medicine for treating chronic kidney disease and preparation thereof |
| 06/14/2011 | USRE42462 Carboxylic acid derivatives, their preparation and use |
| 06/14/2011 | US7960433 Treatment of chemokine mediated diseases |
| 06/14/2011 | US7960416 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization |
| 06/14/2011 | US7960394 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders |
| 06/14/2011 | US7960369 Receptor function regulator |
| 06/14/2011 | CA2496676C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/14/2011 | CA2480678C New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 06/14/2011 | CA2451859C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 06/14/2011 | CA2443325C Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 06/14/2011 | CA2437966C 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical |
| 06/14/2011 | CA2430669C Synthesis of 3-amino-thalidomide and its enantiomers |
| 06/14/2011 | CA2428468C New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 06/14/2011 | CA2426292C Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 06/14/2011 | CA2425311C Ketone compounds and compositions for cholesterol management and related uses |
| 06/09/2011 | WO2011068438A2 Agent for the treatment and prevention of diseases of the male urogenital system |
| 06/09/2011 | WO2011068288A1 Agent for prevention or treatment of benign prostatic hyperplasia comprising a quinazoline derivative |
| 06/09/2011 | WO2011068171A1 Bicyclic nitrogen-containing saturated heterocyclic derivatives |
| 06/09/2011 | US20110136914 Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity |
| 06/09/2011 | US20110136906 Use of hydroxyoleic acid and related compounds in the manufacture of drugs |
| 06/09/2011 | US20110136890 Treatment of fibrotic conditions |
| 06/09/2011 | US20110136876 Altering Pharmacokinetics of Pirfenidone Therapy |
| 06/09/2011 | US20110136869 Compounds Which Selectively Modulate The CB2 Receptor |
| 06/09/2011 | US20110136852 Rapamycin Derivative or an Impdh Inhibitor for Treating Polycystic Kidney Disease |
| 06/09/2011 | US20110136828 Substituted n-oxide pyrazine derivatives |
| 06/09/2011 | US20110136824 Urotensin ii receptor antagonists |
| 06/09/2011 | US20110136814 Diazepine and Diazocane Compounds As MC4 Agonists |
| 06/09/2011 | US20110136768 Imatinib mesylate for the treatment of nephrogenic systemic fibrosis |
| 06/09/2011 | US20110136733 Analogues of glucose-dependent insulinotropic polypeptide |
| 06/09/2011 | US20110136725 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal |
| 06/09/2011 | US20110136724 Analogues of glucose-dependent insulinotropic polypeptide |
| 06/09/2011 | US20110135741 Sustained-release composition and method for producing the same |
| 06/09/2011 | US20110135738 Single dosage pharmaceutical formulation comprising eprosartan mesylate |
| 06/09/2011 | US20110135700 In situ bulking composition |
| 06/09/2011 | US20110135594 Oxindolyl inhibitor compounds |
| 06/09/2011 | US20110135574 Methods of treating kidney disease |
| 06/09/2011 | DE102009056746A1 Transdermales therapeutisches System für die Verabreichung von Peptiden Transdermal therapeutic system for the administration of peptides |
| 06/08/2011 | EP2330193A1 Improved antibody molecule |
| 06/08/2011 | EP2329823A1 Method for improving absorbability of preparation, and preparation having improved absorbability |
| 06/08/2011 | EP2328892A1 Oxotetrahydrofuran-2-yl-benzimidazole derivative |
| 06/08/2011 | EP2328889A1 Acetyl pyrrolidinyl indole derivative |
| 06/08/2011 | EP2328868A1 Novel compounds active as muscarinic receptor antagonists |
| 06/08/2011 | EP2328583A1 New therapeutic use of drotaverine |
| 06/08/2011 | EP2125021B1 Combination therapy of lower urinary tract disorders with 2 ligands and nsaids |
| 06/08/2011 | EP2099462B1 Pharmaceutical preparation for the treatment of inflammatory diseases of the urogenital tract |
| 06/08/2011 | EP1937264B1 Combination therapy for the treatment of urinary frequency, urinary urgency and urinary incontinence |
| 06/08/2011 | EP1427427B1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 06/08/2011 | EP1300407B2 Carbamates derived from arylalkylamines |
| 06/08/2011 | CN102089303A Nitrogenated heterocyclic compound |
| 06/08/2011 | CN102089302A Nitrogenated bicyclic heterocyclic compound |
| 06/08/2011 | CN102089283A Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 06/08/2011 | CN102089281A Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 06/08/2011 | CN102089277A Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 06/08/2011 | CN102089262A Derivatives of 3-(2-hydroxy-5-methyphenyl)-n,n-diisopropyl-3-phenylpropylamine and methods of use thereof |
| 06/08/2011 | CN102088974A Treatment of bladder diseases with a tlr7 activator |
| 06/08/2011 | CN102088970A Improving renal function with quercetin-containing compositions |